Results 41 to 50 of about 3,005,108 (342)
Gastric Neuroendocrine Tumor [PDF]
The Surgery Journal, 2021 AbstractGastric neuroendocrine tumor (gNET) is a rare carcinoid of the stomach whose incidence is increasing due to widespread use of upper gastrointestinal endoscopy (UGIE). There are four types of gNETs with different management strategies and prognosis. Here, we present a patient who came with abdomen pain and intermittent melena.
Naresh Kargwal +3 more
openaire +3 more sources
Annals of Gastroenterological Surgery, 2021 Aim Neuroendocrine tumors (NETs) are one of the subtypes of neuroendocrine neoplasms and are defined as epithelial neoplasms with predominant neuroendocrine differentiation.
Tatsuro Yamaguchi +11 more
doaj +1 more source
Indian Journal of Urology, 2009 Neuroendocrine tumors (NETs) are uncommon tumors that exhibit a wide range of neuroendocrine differentiation and biological behavior. Primary NETs of the kidney, including carcinoid tumor, small cell carcinoma (SCC), and large cell neuroendocrine carcinoma (LCNEC) are exceedingly rare.The clinicopathologic features of renal NETs diagnosed at a single ...
Ming Zhou, Brian R. Lane, George Jour
openaire +3 more sources
Neuroendocrine tumors of the gallbladder (Review)
Oncology Letters, 2020 A gallbladder neuroendocrine neoplasm (GB-NEN) is a unique heterogeneous neoplasm, originating from neuroendocrine cells and able to secrete peptides as its neurotransmitter. Among all the neuroendocrine tumors (NETs), the GB-NEN prevalence is 0.5%, which accounts for ~2.1% of all gallbladder tumors.
Chunyuan Niu +5 more
openaire +4 more sources
Neuroendocrine tumors of the prostate [PDF]
Modern Pathology, 2018 Neuroendocrine (NE) differentiation in tumors of the prostate or in the setting of prostate cancer (PCa) is rare. A survey of these lesions is presented, including usual PCa with focal NE marker-positive cells, Paneth cell-like change, prostatic 'carcinoid', high-grade NE carcinoma, as well as other tumors that do not fit neatly into these categories ...
S. Fine
semanticscholar +4 more sources
Frontiers in Neuroendocrinology, 2001 Tumor markers used in the diagnosis and follow-up of patients with neuroendocrine tumors are in most instances not specific for a given tumor and circulate under normal conditions in the serum, making their use as an early diagnostic tool difficult (low sensitivity).
Leo J. Hofland +2 more
openaire +2 more sources
Endocrine Connections, 2016 To date, the value of fasting plasma acylated ghrelin (AG) and unacylated ghrelin (UAG) as potential novel biomarkers in patients with neuroendocrine tumors (NETs) is unknown.The aims of this study are to (i) compare fasting AG and UAG levels between ...
Roxanne C S van Adrichem +6 more
doaj +1 more source
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”
Cancer Treatment and Research Communications, 2022 Background: Bone metastases (BM) are related to worse outcome in patients with neuroendocrine neoplasms (NENpts). Aim: Assess utility of serum tumor markers (STM) for detection of BM in lung NENpts.
Violetta Rosiek +2 more
doaj
Gastroenteropancreatic Neuroendocrine Tumors
Ca, 2018 Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their incidence has steadily increased in ...
M. Cives, J. Strosberg
semanticscholar +1 more source
Endocrine Connections, 2023 Background: Updated epidemiological data of neuroendocrine tumors are currently lacking. Thus, we performed epidemiological and survival analyses on a large cohort of patients with neuroendocrine tumors and developed a new nomogram to predict survival.
Peiwen Wu +3 more
doaj +1 more source